Data / Form D filings / Denali Therapeutics Inc.
Denali Therapeutics Inc.: Form D filing
Denali Therapeutics Inc., a biotechnology company in South San Francisco, CA, filed a Form D with the SEC in 2024. The latest, on March 1, 2024, reports $499.7 million sold of a $499.7 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 161 OYSTER POINT BLVD., South San Francisco, CA, 94080
- Phone
- (650) 866-8548
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1714899
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | New notice | $499,732,711 | $499,732,711 | 11 | Feb 29, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Carole O. Ho | Executive Officer | |
| Vicki L. Sato | Director | |
| Nancy A. Thornberry | Director | |
| Peter S. Klein | Director | |
| Marc P. Tessier-Lavigne | Director | |
| Jay T. Flatley | Director | |
| David P. Schenkein | Director | |
| Erik T. Harris | Director | |
| Steve E. Krognes | Director | |
| Jennifer O. Cook | Director | |
| Ryan Watts | Executive Officer, Director | |
| Alexander O. Schuth | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 26, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Denali Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.